Wegovy®️ pill (oral semaglutide) recommended by CHMP for approval in the EU as the first oral GLP-1 representing the most efficacious oral obesity treatment in its class
With a mean weight loss of 16.6%[1], Wegovy®️ pill demonstrates best-in-class weight-loss efficacy and is












